Navigation Links
Physicians Expect More Out of Tablet-Toting Pharmaceutical Sales Reps, Study Finds
Date:7/31/2013

NEW YORK, July 31, 2013 /PRNewswire/ -- With the tablet maturing as a device and adoption by pharmaceutical sales forces at near-universal levels, physicians give most tablet details middling ratings, according to the new ePharma Physician® 2013 study from healthcare market research and advisory firm Manhattan Research.

(Logo:  http://photos.prnewswire.com/prnh/20130103/MM36806LOGO )

While 54 percent of physicians participating in the ePharma Physician® 2013 study agreed that tablets make meetings with company representatives more valuable than those without the devices, there's clear room for improvement. Biopharma firms must understand where tablets can add pizzazz to a detail – animations of a novel mechanism of action, for example – and make sure they haven't overlooked basics like intuitive navigation and responsive design.

That's one of a number of opportunities for biopharmaceutical company engagement of physicians identified by the study, for which Manhattan Research surveyed 1,831 US physicians online in Q2 2013. Key findings are summarized in a white paper, Technology and Touchpoints for Physician Engagement in a Time of Change. Among them are:

  • Where reps misstep in the tablet "sales dance" and how to master it
  • How physicians use pharmaceutical company product sites and the need for manufacturers to move beyond the Brand.com to reach healthcare professionals online
  • What physicians want from pharmas as they struggle to adapt to a fast-changing healthcare landscape roiled by the rise of Accountable Care Organizations and implementation of the Affordable Care Act

"In the three years since the iPad's debut, pharmaceutical firms have put tablets in the hands of nearly all of their sales representatives," said Vice President of Research Monique Levy. "The challenge now lies in creating compelling content and crystalizing learning moments that physicians expect and the devices excel at."

Download the Technology and Touchpoints for Physician Engagement in a Time of Change White Paper
This complimentary white paper is just a small preview of the in-depth data and analysis available to subscribing clients of the ePharma Physician® study. To access the white paper, please visit the white paper page.

About ePharma Physician® 2013
ePharma Physician® is Manhattan Research's market research study and syndicated advisory service exploring physician adoption of digital channels for prescription drug information, including through various types of online promotion programs and customer service options from pharma companies. Tablet-assisted in-person sales interactions and their impact on clinical decisions and satisfaction are also assessed. ePharma Physician® 2013 was fielded online in Q2 2013 among 1,831 physicians who are ePharma Physicians, or who use digital channels for pharma resources and connecting with reps. The data can be segmented across a variety of target specialist audiences, including PCPs, pediatricians, cardiologists, oncologists, gastroenterologists and OB/GYNs. For more information, please visit www.manhattanresearch.com/epp.

About Manhattan Research
Manhattan Research, a Decision Resources Group company, conducts annual research studies covering digital health trends among healthcare professionals and consumers in the Americas, Europe, and Asia. Broad research can be segmented by target specialist and therapeutic audiences. For more information, please contact sales@manhattanresearch.com, call 1.888.680.0800, ext 2, or visit www.manhattanresearch.com.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:
Manhattan Research 
Stephanie Cooper
212-255-1368 
scooper@manhattanresearch.com


'/>"/>
SOURCE Manhattan Research
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. American Academy of Family Physicians Foundation Launches Cities for Life
2. CentraState and Freehold Radiology Group train physicians from China
3. New Published Guidelines to Help Physicians Diagnose and Treat Lupus Kidney Disease
4. Ameritox Announces Educational Resources to Help Physicians Navigate Complex Compliance Issues
5. "AWAKEN" Survey Finds Only 50 Percent of Americans Understand Significant Health Impact of Narcolepsy, and Many Physicians Not Comfortable Diagnosing the Sleep Disorder
6. Physicians Practice Recognized for Print and Digital Excellence
7. HealthWarehouse.com and Northwest Physicians Network Partner to Provide Exclusive Discount Pharmacy Services to Patients
8. The American Society of Interventional Pain Physicians Announces Guidelines for Responsible Prescribing of Pain-Killers for Chronic Non-Cancer Pain
9. Homecare Community Dismayed that Medicare Will Start Prior Authorization for Wheelchairs without a Clinical Template for Physicians to Document Need
10. Physicians Find Medical Billers and Coders Within 48 Hours of Posting Jobs with MBC
11. Physicians Capital Investments, Physicians Capital Markets, and EDGE Realty Capital Markets announce a new strategic initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
Breaking Medicine News(10 mins):